Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

China Busts Counterfeit Plavix Ring In Ongoing Crackdown

This article was originally published in PharmAsia News

Executive Summary

First Viagra, then anticancer drugs, now a best-selling blood thinner. Plavix is the latest target to be unveiled in the nationwide hunt for fake drugs in China, where ring leaders are now using social media to mask their activities and cast a wide net around the vast country, targeting patients taking some of the most prescribed drugs from multinational drug makers.


Related Content

2016 Review: Pricing, R&D Issues Dominate China Commercial Arena
When Crisis Hits, Sanofi Turns To Digital Transformation In China


Related Companies